Cargando…
Protection from cigarette smoke‐induced vascular injury by recombinant human relaxin‐2 (serelaxin)
Smoking is regarded as a major risk factor for the development of cardiovascular diseases (CVD). This study investigates whether serelaxin (RLX, recombinant human relaxin‐2) endowed with promising therapeutic properties in CVD, can be credited of a protective effect against cigarette smoke (CS)‐indu...
Autores principales: | Pini, Alessandro, Boccalini, Giulia, Baccari, Maria Caterina, Becatti, Matteo, Garella, Rachele, Fiorillo, Claudia, Calosi, Laura, Bani, Daniele, Nistri, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831370/ https://www.ncbi.nlm.nih.gov/pubmed/26915460 http://dx.doi.org/10.1111/jcmm.12802 |
Ejemplares similares
-
Human Relaxin-2 (Serelaxin) Attenuates Oxidative Stress in Cardiac Muscle Cells Exposed In Vitro to Hypoxia–Reoxygenation. Evidence for the Involvement of Reduced Glutathione Up-Regulation
por: Nistri, Silvia, et al.
Publicado: (2020) -
Chronic Exposure to Cigarette Smoke Affects the Ileum and Colon of Guinea Pigs Differently. Relaxin (RLX-2, Serelaxin) Prevents Most Local Damage
por: Traini, Chiara, et al.
Publicado: (2022) -
Porcine Relaxin but Not Serelaxin Shows Residual Bioactivity after In Vitro Simulated Intestinal Digestion—Clues for the Development of New Relaxin Peptide Agonists Suitable for Oral Delivery
por: Pacini, Lorenzo, et al.
Publicado: (2022) -
Relaxin influences ileal muscular activity through a dual signaling pathway in mice
por: Idrizaj, Eglantina, et al.
Publicado: (2018) -
Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis
por: Yu, Ling, et al.
Publicado: (2018)